1. Home
  2. PDYN vs BCYC Comparison

PDYN vs BCYC Comparison

Compare PDYN & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Palladyne AI Corp.

PDYN

Palladyne AI Corp.

HOLD

Current Price

$5.62

Market Cap

287.2M

Sector

Industrials

ML Signal

HOLD

Logo Bicycle Therapeutics plc

BCYC

Bicycle Therapeutics plc

HOLD

Current Price

$3.87

Market Cap

291.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDYN
BCYC
Founded
1983
2009
Country
United States
United Kingdom
Employees
70
N/A
Industry
Wholesale Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
287.2M
291.8M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
PDYN
BCYC
Price
$5.62
$3.87
Analyst Decision
Buy
Buy
Analyst Count
3
10
Target Price
$9.67
$13.90
AVG Volume (30 Days)
1.0M
335.4K
Earning Date
05-05-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$384.48
N/A
Revenue Next Year
$63.16
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.14
$3.80
52 Week High
$10.73
$9.16

Technical Indicators

Market Signals
Indicator
PDYN
BCYC
Relative Strength Index (RSI) 51.82 38.69
Support Level $4.74 N/A
Resistance Level $6.35 $4.52
Average True Range (ATR) 0.32 0.16
MACD 0.08 -0.03
Stochastic Oscillator 95.43 20.34

Price Performance

Historical Comparison
PDYN
BCYC

About PDYN Palladyne AI Corp.

Palladyne AI Corp is a software company focused on autonomy for robotic systems and solutions. Its artificial intelligence and machine learning software seeks to revolutionize the capabilities of robots, enabling them to observe, learn, reason, and act in structured and unstructured environments. AI and ML software platform of the company empowers robots to perceive variations or changes in the real-world environment, enabling them to autonomously maneuver and manipulate objects accurately in response. Palladyne AI software has wide application, including in industries such as automotive, aviation, construction, defense, general manufacturing, infrastructure inspection, logistics and warehousing.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.

Share on Social Networks: